Genital Herpes Vaccine Appears Safe and Well Tolerated
Monday, 09 May 2005
NEW YORK (Reuters Health) - The largest study to date of a genital herpes vaccine under development by GlaxoSmithKline indicates that it is safe, well-tolerated and immunogenic, researchers report in the May 1st issue of Clinical Infectious Diseases.
read more
|
Problem Drinking Contributes to STD Prevalence
Monday, 21 March 2005
NEW YORK (Reuters Health) - A literature review suggests that there is, as might be imagined, an association between sexually transmitted diseases and alcohol consumption, according to Pennsylvania-based researchers.
read more
|
Los Angeles Clinic Used Wrong Drug to Treat Syphilis
Friday, 11 March 2005
NEW YORK (Reuters Health) - Over a period of 5 years, a clinic in Los Angeles used a nonrecommended preparation of penicillin to treat nearly 700 syphilis patients and their contacts, according a study in the March 11th issue of the Morbidity and Mortality Weekly Report.
read more
|
Human Papilloma Virus (HPV) DNA Testing of Brushed Specimens is the Optimal Approach to Diagnosing HPV Infection in Men
Tuesday, 08 March 2005
BERKELEY, CA (UroToday Inc.) - Dr. Sergio Nicolau and colleagues from Sao Paulo, Brazil performed a study to determine the prevalence of human papilloma virus (HPV) in the male partners of HPV-infected women, as well as define the most affected site in genitalia and compare diagnostic methods for the detection of HPV infection in men. Their findings were published in the February 2005 edition of Urology.
read more
|
Topical BCG Shows Promise as Treatment for Genital Warts
Tuesday, 08 March 2005
NEW YORK (Reuters Health) - Topical therapy with viable bacille Calmette-Guerin (BCG) can clear all condylomata acuminata in 92% of patients, findings from a pilot study show.
read more
|
Expedited Treatment of Sex Partners Cuts Gonorrhea, Chlamydia Recurrence
Thursday, 17 February 2005
NEW YORK (Reuters Health) - Immediately treating the sex partners of patients infected with gonorrhea or chlamydia can reduce rates of persistent or recurrent infection with these pathogens.
read more
|
Patient-Delivered Partner Therapy for the Treatment of Sexually Transmitted Diseases is Inconsistently Used by U.S. Physicians
Wednesday, 16 February 2005
BERKELEY, CA (UroToday Inc.) - Patient-delivered partner therapy (PDPT) is the practice of giving a patient diagnosed with a sexually transmitted disease (STD) medication to treat their partner.
read more
|
Online Syphilis Testing Convenient Alternative to Clinic Testing
Tuesday, 15 February 2005
NEW YORK (Reuters Health) - Online syphilis testing is a convenient alternative to standard testing in a clinic that could potentially increase screening rates, according to a report in the February issue of Sexually Transmitted Diseases.
read more
|
Two Cases of Lymphogranuloma Venereum Reported in New York
Friday, 04 February 2005
NEW YORK (Reuters) - Two New Yorkers have been diagnosed with lymphogranuloma venereum (LGV), which is rare in the region but is spreading among gay and bisexual men in Europe, the city health commissioner said on Wednesday.
read more
|
Circumcision Decreases Risk of HIV But Not Other STIs
Wednesday, 26 January 2005
NEW YORK (Reuters Health) - Even though male circumcision seems to reduce the incidence of HIV, the procedure appears to have no effect on susceptibility to other sexually transmitted infections (STIs), the results of a study conducted in Uganda suggests.
read more
|
Genital Wart Incidence Rising in US
Thursday, 06 January 2005
NEW YORK (Reuters Health) - The incidence of genital warts appears to be increasing in the US, according to a study based on insurance claims data.
read more
|
Fluoroquinolone-Resistant Gonorrhea Increasing in Hawaii
Friday, 31 December 2004
NEW YORK (Reuters Health) - Ciprofloxacin resistance in Neisseria gonorrhoeae isolates from Hawaii has risen from less than 1.5% before 1997 to 10.4% in 2000, according to a report in the December issue of Sexually Transmitted Diseases.
read more
|
Improved Screening Prompts Jump in Chlamydia Cases
Wednesday, 01 December 2004
ATLANTA (Reuters) - The number of sexually transmitted chlamydia infections reported in the United States rose more than 5% last year, the Centers for Disease Control and Prevention (CDC) said on Monday.
read more
|
England's National Chlamydia Screening Program Off to a Good Start
Wednesday, 24 November 2004
NEW YORK (Reuters Health) - Public health officials in England are encouraged by results achieved during the first phase of the country's National Chlamydia Screening Programme (NCSP).
read more
|
Cefuroxime a Poor Choice for Gonorrhorea in the UK
Monday, 22 November 2004
NEW YORK (Reuters Health) - Ceftriaxone or cefixime are the drugs of choice to replace ciprofloxacin for the treatment of gonorrhoea in the UK, Dr. Catherine A. Ison from the Health Protection Agency in London and colleagues remind clinicians in the October issue of Sexually Transmitted Infections.
read more
|
Sexually Transmitted Disease 
